Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
3.010
+0.080 (2.73%)
Jun 24, 2025, 11:25 AM - Market open

Grace Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2016 - 2020
Period Ending
Jun '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
Market Capitalization
4231322154120
Upgrade
Market Cap Growth
-2.84%-2.84%56.90%-62.03%-55.00%250.73%
Upgrade
Enterprise Value
18207-10892
Upgrade
Last Close Price
2.932.283.422.767.3228.80
Upgrade
Debt / Equity Ratio
---0.010.000.00
Upgrade
Asset Turnover
-----0.01
Upgrade
Quick Ratio
11.5311.5314.098.4113.5638.80
Upgrade
Current Ratio
11.7711.7714.268.5913.8939.50
Upgrade
Return on Equity (ROE)
-14.91%-14.91%-19.82%-48.15%-11.98%-57.33%
Upgrade
Return on Assets (ROA)
-14.35%-14.35%-9.25%-10.96%-7.94%-15.70%
Upgrade
Return on Capital (ROIC)
-16.24%-16.24%-10.83%-12.86%-9.23%-19.45%
Upgrade
Buyback Yield / Dilution
-27.10%-27.10%-28.16%-21.09%-148.46%-40.25%
Upgrade
Updated Jun 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q